Functional amplification and preservation of human gut microbiota

Archive ouverte

Gaci, Nadia | Chaudhary, Prem Prashant | Tottey, William | Alric, Monique | Brugère, Jean-François

Edité par CCSD ; Co-Action Publishing -

International audience. Background: The availability of fresh stool samples is a prerequisite in most gut microbiota functional studies. Objective: Strategies for amplification and long-term gut microbiota preservation from fecal samples would favor sample sharing, help comparisons and reproducibility over time and between laboratories, and improve the safety and ethical issues surrounding fecal microbiota transplantations.Design: Taking advantage of in vitro gut-simulating systems, we amplified the microbial repertoire of a fresh fecal sample and assessed the viability and resuscitation of microbes after preservation with some common intracellular and extracellular acting cryoprotective agents (CPAs), alone and in different combinations. Preservation efficiencies were determined after 3 and 6 months and compared with the fresh initial microbiota diversity and metabolic activity, using the chemostat-based Environmental Control System for Intestinal Microbiota (ECSIM) in vitro model of the gut environment. Microbial populations were tested for fermentation gas, short-chain fatty acids, and composition of amplified and resuscitated microbiota, encompassing methanogenic archaea.Results: Amplification of the microbial repertoire from a fresh fecal sample was achieved with high fidelity. Dimethylsulfoxide, alone or mixed with other CPAs, showed the best efficiency for functional preservation, and the duration of preservation had little effect.Conclusions: The amplification and resuscitation of fecal microbiota can be performed using specialized in vitro gut models. Correct amplification of the initial microbes should ease the sharing of clinical samples and improve the safety of fecal microbiota transplantation.

Suggestions

Du même auteur

Methanomethylophilus alvi gen. nov., sp. nov., a Novel Hydrogenotrophic Methyl-Reducing Methanogenic Archaea of the Order Methanomassiliicoccales Isolated from the Human Gut and Proposal of the Novel Family Methanomethylophilaceae fam. nov.

Archive ouverte | Borrel, Guillaume | CCSD

International audience. The methanogenic strain Mx-05T was isolated from the human fecal microbiome. A phylogenetic analysis based on the 16S rRNA gene and protein marker genes indicated that the strain is affiliate...

Le concept "Archaebiotics", vers de nouveaux probiotiques préventifs des maladies cardiovasculaires ?

Archive ouverte | Brugère, Jean-François | CCSD

Communication orale: Brugère J.F.Communication orale: Brugère J.F.. D'origine intestinale, la trimethylamine (TMA) provient du métabolisme de divers nutriments par le microbiote intestinal (phosphatidylcholine, chol...

Archaebiotics Proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease

Archive ouverte | O’toole, Paul W | CCSD

International audience. Trimethylamine (TMA) is produced by gut bacteria from dietary ingredients. In individuals with a hereditary defect in flavin-containing monooxygenase 3, bacterial TMA production is believed t...

Chargement des enrichissements...